A Review on Fluconazole

Sharanpreet kaur; Navreet Kaur; Gursimran Kaur; Prabhat Kumar

doi:10.55544/jrasb.2.3.6

Authors

Kaur Sharanpreet Assistant Professor, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Rupnagar, Punjab, INDIA.
Kaur Navreet Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Rupnagar, Punjab, INDIA.
Kaur Gursimran Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Rupnagar, Punjab, INDIA.
Kumar Prabhat Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Rupnagar, Punjab, INDIA.

DOI:

https://doi.org/10.55544/jrasb.2.3.6

Keywords:

fluconazole, dissolution, solubility

Abstract

The improvement of a significant dissolution manner for drug merchandise with restrained water solubility has been a project to the pharmaceutical industry. fluconazole (BCS Class 1 drug) is an anti-fungal drug. There isn't any reputable dissolution medium to be had withinside the literature. In the prevailing study, parameters inclusive of solubility, medium pH, surfactant type, dissolution behaviour of formulations, impact of sink situations, stability, and discriminatory impact of dissolution checking out had been studied for the choice of a right dissolution medium. Results of solubility facts found out that solubility elevated with a growth in pH. The drug and advertised formulations had been strong withinside the dissolution media used. An agitation velocity of fifty rpm confirmed a greater discriminating drug launch profile than seventy-five rpm. The discriminating dissolution technique for fluconazole components is paddle at 50 rpm, 900 mL pH 6.8 phosphate buffer, more than 80% of the label quantity is launched over 60 minutes.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Dressman, J. B.; Amidon, G. L.; Reppas, C.; Shah, V. P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 1998, 15, 11–22.

Pillay, V.; Fassihi, R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Controlled Release 1998, 55, 45–55.

SUPAC–MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Post Approval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, U.S. Government Printing Office: Washington, DC, 1997.

Shah, V. P.; Konecny, J. J.; Everett, R. L.; Mc Cullough, B.; Noorizadeh, A. C.; Skelly, J. P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 1989, 6 (7), 612–618.

Carstensen, J. T. Physico-chemical aspects of drug release. In Formulation and Preparation of Dosage Forms, Proceedings of the 37th International Congress of Pharmaceutical Sciences of F.I.P., The Hague, Netherlands, Sept 5–9, 1977; Polderman, J., Ed.; Elsevier: Amsterdam; 1977.

Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413–420.

Jinno, J.; Oh, D.; Crison, J. R.; Amidon, G. L. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J. Pharm. Sci. 2000, 89 (2), 268–274.

Pillay, V.; Fassihi, R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Controlled Release 1998, 55, 45–55.

Denollin S, Vanbelle H, Goossens F, et al.: Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother 11:500- 513, 1977.

Shigematsu ML, Uno J, Arai T: Effect of ketoconazole on isolated mitochondria from Candida albicans. Antimicrob Agents Chemother 21:919-924.

Uno J, Shigematsu ML, Aria T: Primary site of action of ketoconazole on Candida albicans. Antimicrob Agents Chemother 21:912-918, 1982.

Fortunato, D. Dissolution Method Development for Immediate Release Solid Oral Dosage Forms. Dissolution Technol. 2005, 12 (3), 12–15.

Balakrishnan, A.; Rege, B. D.; Amidon, G. L.; Polli, J. E. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. J. Pharm. Sci. 2004, 93, 2064–2075

Phillips RJM, Watson SA, McKay FF: An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice. Br J Clin Pract 44:219-222, 1990.

DeWit S, Goossens H, Weerts D, Clumeck N: Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1:746-748, 1989.

Powderly WG, Saag MS, Cloud CA, et al.: A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 326:793- 798, 1992.

Jacobson MA, Hanks DK, Ferrell LD: Fatal acute hepatic injury arising during fluconazole therapy. Arch Intern Med 154:102-104.